Xi'an ESWIN Material Technology(688783)
Search documents
西安奕材11月3日获融资买入7646.28万元,融资余额2.97亿元
Xin Lang Cai Jing· 2025-11-04 01:45
Core Viewpoint - Xi'an Yichai experienced a decline of 3.97% on November 3, with a trading volume of 923 million yuan, indicating market volatility and investor sentiment towards the company [1]. Group 1: Financing and Trading Data - On November 3, Xi'an Yichai had a financing buy-in amount of 76.46 million yuan and a financing repayment of 73.43 million yuan, resulting in a net financing buy of 3.03 million yuan [1]. - As of November 3, the total balance of margin trading for Xi'an Yichai was 297 million yuan, which represents 6.53% of its circulating market value [1]. - There were no shares repaid or sold in the securities lending market on November 3, with a total lending balance of 0 [1]. Group 2: Company Overview and Financial Performance - Xi'an Yichai, established on March 16, 2016, focuses on the research, production, and sales of 12-inch silicon wafers, with its main revenue sources being semiconductor silicon test wafers (40.77%), polishing wafers (34.39%), and epitaxial wafers (24.48%) [1]. - As of October 28, the number of shareholders for Xi'an Yichai reached 165,500, an increase of 266,891.94% compared to the previous period, with an average of 994 circulating shares per person [2]. - For the period from January to September 2025, Xi'an Yichai reported a revenue of 1.933 billion yuan, reflecting a year-on-year growth of 34.80%, while the net profit attributable to the parent company was -558 million yuan, showing a year-on-year increase of 5.30% [2].
“打新定期跟踪”系列之二百三十六:科创未盈利新股上市,西安奕材上市均价涨幅高达211%
Huaan Securities· 2025-11-03 12:59
- The report tracks the recent IPO performance in the A-share market, including the Sci-Tech Innovation Board, ChiNext, and Main Board, assuming all stocks are successfully subscribed and sold at the market average price on the first trading day, ignoring lock-up restrictions[2][10][39] - For A-class accounts with a scale of 2 billion, the IPO yield since the beginning of 2025 until October 31, 2025, is 2.65%, while for B-class accounts of the same scale, the yield is 2.23%[2][10][39] - For larger accounts with a scale of 10 billion, the IPO yield for A-class accounts is 0.96%, and for B-class accounts, it is 0.73%[2][10][39] - The average first-day increase for Sci-Tech Innovation Board stocks is 219.94%, while for ChiNext stocks, it is 244.28%[2][18][39] - The report calculates the theoretical IPO yield using the formula: $ Class Full Subscription Quantity = Maximum Subscription Limit × Average Class Offline Winning Rate $ $ Full Subscription Yield = (First Opening Price - Initial Offering Price) × Full Subscription Quantity $[38][39][41] - The full subscription yield for individual stocks mostly ranges between 5 to 100 thousand yuan, with the highest yields being C奕材-U (98.18 thousand yuan), C禾元-U (78.03 thousand yuan), and 联合动力 (50.81 thousand yuan)[38][39][41] - The report provides detailed monthly IPO yield calculations for different account scales (1.5 billion, 2 billion, 3 billion, 5 billion, and 10 billion) across Sci-Tech Innovation Board, ChiNext, and Main Board, assuming 90% capital utilization efficiency and all quotes successfully included[39][42][46]
今年以来88只新股已发行,共募资914.07亿元
Zheng Quan Shi Bao Wang· 2025-11-03 07:32
Summary of Key Points Core Viewpoint - The article discusses the recent issuance of new stocks in China, highlighting the total amount raised and the distribution of funds across various sectors and regions. It emphasizes the significant fundraising activities of specific companies and the overall trends in the stock market for the year. Group 1: New Stock Issuance - A new stock, Beikang Testing, issued 28.32 million shares at a price of 6.70 yuan, raising 190 million yuan [1] - As of November 3, 88 companies have gone public this year, raising a total of 91.407 billion yuan, with an average fundraising of 1.039 billion yuan per company [1] - 19 companies raised over 1 billion yuan, with one company exceeding 10 billion yuan [1] Group 2: Fundraising by Sector - The Shanghai main board saw 21 new stocks issued, raising 41.405 billion yuan; the Shenzhen main board had 10 new stocks raising 7.925 billion yuan; the ChiNext board had 27 new stocks raising 19.316 billion yuan; the Sci-Tech Innovation board had 10 new stocks raising 16.736 billion yuan; and the Beijing Stock Exchange had 20 new stocks raising 6.024 billion yuan [1] - Huadian New Energy raised the most funds this year at 18.171 billion yuan, primarily for wind and solar power projects [1] - Other notable fundraisers include C Yicai with 4.636 billion yuan and Zhongce Rubber with 4.066 billion yuan [1] Group 3: Pricing and Regional Distribution - The average initial public offering (IPO) price this year is 20.99 yuan, with four companies priced above 50 yuan, the highest being Tianyouwei at 93.50 yuan [2] - The majority of new stock issuances are concentrated in Jiangsu, Guangdong, and Zhejiang, with 23, 16, and 14 companies respectively [2] - The top three provinces by fundraising amount are Fujian (18.171 billion yuan), Jiangsu (15.634 billion yuan), and Guangdong (13.916 billion yuan) [2]
FundPark完成7100万美元融资;三一重工登陆港交所,最新市值为2128.98亿港元丨全球投融资周报10.25-10.31
创业邦· 2025-11-02 01:35
Core Viewpoint - The article provides an overview of the latest trends in investment and financing activities in the domestic market, highlighting key sectors and significant financing events. Group 1: Investment Overview - This week, there were 109 disclosed financing events in the domestic primary market, an increase of 12 compared to the previous week. Among these, 36 events disclosed financing amounts, totaling 4.786 billion RMB, with an average financing amount of 133 million RMB [7]. - The most active sectors in terms of financing events were intelligent manufacturing, artificial intelligence, and healthcare, with 21, 16, and 13 events respectively [9]. Group 2: Sector Highlights - In terms of disclosed financing amounts, artificial intelligence led with a total financing scale of approximately 1.055 billion RMB. Notably, the bionic robot developer "Wubai Intelligent" secured nearly 500 million RMB in Series A financing [9][10]. - The healthcare sector followed with a disclosed financing total of 670 million RMB, where the medical isotope developer "Nuclear Element Innovation" received 430 million RMB in Series A financing [10]. Group 3: Regional Distribution - The disclosed financing events were primarily concentrated in Jiangsu, Zhejiang, and Guangdong, with Jiangsu reporting 24 events, Zhejiang 19 events, and Guangdong 18 events [14][17]. Group 4: Stage Distribution - The stage distribution of the disclosed financing events showed that 81 were early-stage, 24 were growth-stage, and 4 were late-stage [17]. Group 5: Major Financing Events - The article mentions significant financing events, including the acquisition of 70% of the semiconductor packaging materials manufacturer "Huawei Electronics" by Huahai Chengke for 1.12 billion RMB [35][37]. Group 6: Active Investment Institutions - The most active investment institutions this week included CRRC Capital with 4 investment events, Shenzhen Capital Group with 3, and Legend Capital with 2 [24]. Group 7: IPO Highlights - A total of 8 companies were monitored for IPOs this week, with the highest market capitalization being "Sany Heavy Industry" at 212.898 billion HKD. All listed companies had previously received VC/PE or CVC investments [28][29].
三家未盈利企业登陆科创板 科创成长层包容性适应性凸显
Zhong Guo Jing Ying Bao· 2025-10-31 19:12
Core Points - The listing of three unprofitable high-tech companies on the Sci-Tech Innovation Board marks a significant step in capital market support for technological innovation and new productivity development [2][4] - The establishment of the Sci-Tech Growth Layer enhances market inclusivity and strengthens the capital market's role in serving the real economy [1][10] Group 1: New Listings - Three companies, Bibet (688759.SH), Heyuan Bio (688765.SH), and Xi'an Yicai (688783.SH), were listed on the Sci-Tech Innovation Board, representing the first batch of new registered enterprises in the Sci-Tech Growth Layer [1][2] - Bibet focuses on innovative drug development, with its product BEBT-908 approved for treating various blood cancers and solid tumors [2][3] - Heyuan Bio has developed a leading rice recombinant protein expression system, with its core product HY1001 approved for treating liver cirrhosis [2][3] - Xi'an Yicai specializes in the research, production, and sales of 12-inch silicon wafers, ranking first in mainland China and sixth globally in terms of monthly shipment and production capacity [3] Group 2: Performance of Existing Companies - The 32 existing companies in the Sci-Tech Growth Layer achieved a total revenue of 675.75 billion yuan in 2024, with 29 companies surpassing 100 million yuan in revenue [5][6] - The average annual compound growth rate of revenue for these companies reached 27.87%, outperforming the overall growth rate of the Sci-Tech Innovation Board [6] - In the first half of 2025, these companies reported a year-on-year revenue growth of 37.79% and a significant reduction in losses, with a total loss reduction of 71.23 billion yuan [6][7] Group 3: R&D Investment and Innovation - The existing companies collectively invested 30.6 billion yuan in R&D in 2024, with a median R&D investment-to-revenue ratio of 65.40%, leading the Sci-Tech Innovation Board [6][9] - Since the establishment of the Sci-Tech Board, 22 previously unprofitable companies have achieved profitability, with an average of four companies "delisting" from the unprofitable status each year [6][7] - The Sci-Tech Growth Layer has facilitated significant collaborations, such as the global strategic partnership between Baili Tianheng and Bristol-Myers Squibb, which involved an upfront payment of 800 million USD [8][9] Group 4: Future Outlook - The establishment of the Sci-Tech Growth Layer is expected to attract more technology companies, expanding the coverage of the Sci-Tech Innovation Board and providing a broader market space for quality tech enterprises [10] - The focus on high-level technological self-reliance and the development of new productivity will be key objectives during the 14th Five-Year Plan period, with the Sci-Tech Growth Layer playing a crucial role in this process [10]
2025年1-10月IPO中介机构排名(A股)
Sou Hu Cai Jing· 2025-10-31 02:43
Core Insights - In the period from January to October 2025, a total of 87 new companies were listed on the A-share market, representing an 8.75% increase compared to the same period last year, which had 80 new listings [1] - The total net fundraising amount for these 87 new listings reached 833.81 billion yuan, marking a significant 77.02% increase from 471.02 billion yuan in the same period last year [1] Underwriting Institutions Performance Ranking - A total of 29 underwriting institutions participated in the IPOs of these 87 new companies, with a total of 88 deals completed [2] - The top five underwriting institutions by number of deals are: - 1st: Guotai Junan with 11 deals - 2nd: CITIC Securities with 10 deals - 3rd: Huatai United with 8 deals - 4th: CITIC Jianzhong with 7 deals - 5th: China Merchants Securities with 5 deals [2][3] Law Firms Performance Ranking - In the same period, 28 law firms provided legal services for the IPOs of the 87 new companies [6] - The top five law firms by number of deals are: - 1st: Shanghai Jintiancheng with 13 deals - 2nd: Beijing Deheng and Beijing Zhonglun, both with 7 deals - 4th: Beijing Guofeng with 6 deals - 5th: Shanghai Tongli with 5 deals [6][7] Accounting Firms Performance Ranking - A total of 16 accounting firms provided auditing services for the 87 new listings [9] - The top five accounting firms by number of deals are: - 1st: Rongcheng with 20 deals - 2nd: Tianjian with 16 deals - 3rd: Lixin and Zhonghui, both with 11 deals - 5th: Ernst & Young Hua Ming, KPMG Huazhen, and Zhongshen Zhonghuan, each with 4 deals [9][10]
“地基”上的赶超者:全球12英寸硅片“第六极”西安奕材迎来“黄金期”
Sou Hu Cai Jing· 2025-10-29 16:28
Core Viewpoint - The semiconductor industry, particularly the 12-inch wafer segment, is experiencing significant growth, with Xi'an Yiswei Materials Technology Co., Ltd. emerging as a key player in the market, having recently gone public on the A-share market [3][4]. Group 1: Company Overview - Xi'an Yiswei specializes in the research, production, and sales of 12-inch silicon wafers, ranking as the largest in mainland China and the sixth globally [3]. - The company has established itself as a major supplier for leading domestic wafer foundries and storage IDM manufacturers, achieving significant market penetration [5]. Group 2: Market Dynamics - The demand for 12-inch wafers is driven by the need for advanced logic and storage chips, particularly in the context of AI applications, with 12-inch wafers accounting for over 75% of global silicon wafer shipments in 2024 [4]. - The global market for 12-inch wafers has been dominated by a few established foreign companies, which control 92% of the market share, creating a significant supply gap in China [4]. Group 3: Financial Performance - Xi'an Yiswei's revenue has shown strong growth, with projections of 10.55 billion CNY in 2022, 14.74 billion CNY in 2023, and 21.21 billion CNY in 2024, reflecting a compound annual growth rate of 41.83% [5]. - The company reported a revenue of 13.02 billion CNY in the first half of 2025, marking a year-on-year increase of 45.99% [5]. Group 4: Technological Advancements - Xi'an Yiswei has invested heavily in R&D, with over 10% of its revenue allocated to R&D from 2022 to 2024, resulting in a robust patent portfolio of 1,843 applications, of which 799 are granted [7][9]. - The company has developed a comprehensive core technology system across five key process stages, achieving performance metrics comparable to the top five global manufacturers [7]. Group 5: Supply Chain and Customer Base - The company has successfully validated its products with major clients in the NAND Flash and DRAM sectors, and is expanding its international customer base, having passed qualifications for 161 domestic and international clients [10]. - Xi'an Yiswei is actively working to diversify its supply chain and enhance local supplier capabilities, contributing to the development of the domestic silicon wafer industry [11]. Group 6: Future Outlook - The company is poised for growth as the demand for 12-inch wafers is expected to rise significantly, with projections indicating that by 2026, global demand will exceed 10 million wafers per month [14]. - With its recent IPO, Xi'an Yiswei aims to leverage capital to expand its production capacity and enhance its competitive edge in the global market [12][14].
科创板活跃股榜单:84股换手率超5%
Zheng Quan Shi Bao Wang· 2025-10-29 09:39
Market Performance - The Sci-Tech Innovation Board (STAR Market) index rose by 1.18%, closing at 1489.12 points, with a total trading volume of 4.52 billion shares and a turnover of 232.84 billion yuan [1] - Among the tradable stocks on the STAR Market, 296 stocks closed higher, with 10 stocks increasing by over 10% and 25 stocks rising between 5% and 10% [1] Trading Activity - The average turnover rate for the STAR Market was 2.37%, with 3 stocks having a turnover rate exceeding 20% and 14 stocks between 10% and 20% [1] - The highest turnover rate was recorded by C Yicai at 51.17%, with a closing price increase of 3.88% and a daily trading volume of 2.216 billion yuan [1] - C Heyuan, another new stock, saw a significant increase of 24.28% with a turnover rate of 50.96% and a trading volume of 2.171 billion yuan [1] Sector Analysis - In the high turnover stocks, the electronics sector had the most representation, with 32 stocks, followed by power equipment and computer sectors with 15 and 10 stocks, respectively [2] - Among the high turnover stocks, 49 stocks experienced net inflows of main funds, with Huahong Company, Aters, and Goodway receiving the highest net inflows of 449 million yuan, 418 million yuan, and 116 million yuan, respectively [2] Leverage and Financial Performance - A total of 64 stocks in the high turnover category received net purchases of leveraged funds, with notable increases in financing balances for Ju Chen Co., Huafeng Technology, and Western Superconducting, which saw increases of 462 million yuan, 343 million yuan, and 313 million yuan, respectively [3] - Among the high turnover stocks, 52 companies reported their Q3 earnings, with Zhongyou Technology, Shijia Photon, and Huafeng Technology showing significant net profit growth rates of 1074.35%, 727.74%, and 558.51%, respectively [3]
上峰水泥:出资2亿元作为有限合伙人的中建材新材料(安徽)基金出资6.99亿元投资了西安奕材
Zheng Quan Ri Bao Wang· 2025-10-29 09:10
Group 1 - The company, Shengfeng Cement, has invested 200 million yuan as a limited partner in the China National Building Material New Materials (Anhui) Fund, which has a total investment of 699 million yuan in Xi'an Yicai [1]
"地基"上的赶超者:全球12英寸硅片"第六极"西安奕材迎来"黄金期"
Guo Ji Jin Rong Bao· 2025-10-29 07:51
Core Insights - The semiconductor industry has become a global focal point, with Chinese players like Xi'an Yicai making significant breakthroughs in the 12-inch silicon wafer market, traditionally dominated by overseas giants [1][3][4]. Company Overview - Xi'an Yicai officially listed on the A-share market on October 28, 2023, focusing on the research, production, and sales of 12-inch silicon wafers [3]. - The company is the largest 12-inch silicon wafer manufacturer in mainland China and the sixth largest globally, with a projected average monthly shipment of 625.46 million wafers by 2024 [3][5]. Market Dynamics - The performance and supply capacity of silicon wafers directly impact the competitiveness of the semiconductor industry, especially in the context of the AI era, which demands higher data processing capabilities [3][4]. - The global market for 12-inch silicon wafers is currently dominated by a few overseas companies, which control 92% of the market share, creating a significant supply gap in China [4]. Financial Performance - Xi'an Yicai's revenue has shown a compound annual growth rate (CAGR) of 41.83% from 2022 to 2024, with revenues of 10.55 billion, 14.74 billion, and 21.21 billion respectively [5]. - The company achieved a revenue of 13.02 billion in the first half of 2025, marking a year-on-year increase of 45.99% [5]. Technological Advancements - Xi'an Yicai has invested heavily in R&D, with over 10% of its revenue allocated to R&D from 2022 to 2024, resulting in a total of 1843 patent applications, of which 80% are invention patents [7][9]. - The company has developed a core technology system across five major process stages, achieving performance metrics comparable to the top five global manufacturers [7]. Supply Chain and Client Base - The company has established a strong client base, supplying to major domestic and international wafer foundries, with 30% of its revenue coming from exports [11]. - Xi'an Yicai is recognized as a key player in the local supply chain, actively promoting the localization of upstream suppliers [11]. Capacity Expansion - By the end of 2024, Xi'an Yicai's production capacity is expected to reach 71 million wafers per month, accounting for approximately 7% of the global market [12]. - The company plans to use the funds raised from its IPO to expand its second factory in Xi'an, targeting advanced DRAM and NAND Flash chips [12][14]. Future Outlook - The global demand for 12-inch silicon wafers is projected to exceed 10 million wafers per month by 2026, with Xi'an Yicai aiming to achieve a combined capacity of 1.2 million wafers per month across its facilities [14]. - The semiconductor industry is expected to recover from its downturn, with Xi'an Yicai positioned to capitalize on the growing demand driven by AI and supportive policies [14].